Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | SH3GLB2 |
| Upstream (Parents) |
|---|
| (<<) ACTB → SH3GLB2 |
| (<<) ARHGEF2 → SH3GLB2 |
| (<<) CFL1 → SH3GLB2 |
| (<<) JUND → SH3GLB2 |
| (<<) KCTD5 → SH3GLB2 |
| (<<) MAPKAP1 → SH3GLB2 |
| (<<) MAPKAPK5 → SH3GLB2 |
| (<<) PLD3 → SH3GLB2 |
| (<<) RAVER1 → SH3GLB2 |
| (<<) RHOB → SH3GLB2 |
| (<<) RXRB → SH3GLB2 |
| (<<) SHC1 → SH3GLB2 |
| (<<) TGFB1 → SH3GLB2 |
| (<<) TPP1 → SH3GLB2 |
| (<<) YWHAE → SH3GLB2 |
| Downstream (Children) |
|---|
| SH3GLB2 → ADAM15 (>>) |
| SH3GLB2 → ADRBK1 (>>) |
| SH3GLB2 → ARAF (>>) |
| SH3GLB2 → ATIC (>>) |
| SH3GLB2 → BCL2L1 (>>) |
| SH3GLB2 → CDK4 (>>) |
| SH3GLB2 → CDK5 (>>) |
| SH3GLB2 → CISH (>>) |
| SH3GLB2 → DMPK (>>) |
| SH3GLB2 → E2F3 (>>) |
| SH3GLB2 → EHD1 (>>) |
| SH3GLB2 → FAM129B (>>) |
| SH3GLB2 → FBXO32 (>>) |
| SH3GLB2 → GALK1 (>>) |
| SH3GLB2 → GNB1 (>>) |
| SH3GLB2 → GNB2 (>>) |
| SH3GLB2 → GRK6 (>>) |
| SH3GLB2 → HCN2 (>>) |
| SH3GLB2 → HPCAL1 (>>) |
| SH3GLB2 → IQSEC2 (>>) |
| SH3GLB2 → LOC92249 (>>) |
| SH3GLB2 → MAFF (>>) |
| SH3GLB2 → MAP2K2 (>>) |
| SH3GLB2 → MAPK3 (>>) |
| SH3GLB2 → MKNK2 (>>) |
| SH3GLB2 → MVK (>>) |
| SH3GLB2 → MYL5 (>>) |
| SH3GLB2 → NCOA7 (>>) |
| SH3GLB2 → NRSN2 (>>) |
| SH3GLB2 → OGFR (>>) |
| SH3GLB2 → PAK4 (>>) |
| SH3GLB2 → PDE4C (>>) |
| SH3GLB2 → PDK2 (>>) |
| SH3GLB2 → PRR5 (>>) |
| SH3GLB2 → PRR7 (>>) |
| SH3GLB2 → PTMA (>>) |
| SH3GLB2 → PTMS (>>) |
| SH3GLB2 → RARG (>>) |
| SH3GLB2 → RHBDL1 (>>) |
| SH3GLB2 → RHOC (>>) |
| SH3GLB2 → RHOV (>>) |
| SH3GLB2 → RXRA (>>) |
| SH3GLB2 → SH3GL1 (>>) |
| SH3GLB2 → SOX18 (>>) |
| SH3GLB2 → ST3GAL2 (>>) |
| SH3GLB2 → SULT1A1 (>>) |
| SH3GLB2 → TUBA1A (>>) |
| SH3GLB2 → TUBB2C (>>) |
| SH3GLB2 → VCP (>>) |
| SH3GLB2 → VEGFB (>>) |
| SH3GLB2 → ZFP36L1 (>>) |
